These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27160755)

  • 1. Statins in Stroke Prevention: Present and Future.
    Castilla-Guerra L; Del Carmen Fernandez-Moreno M; Colmenero-Camacho MA
    Curr Pharm Des; 2016; 22(30):4638-4644. PubMed ID: 27160755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.
    Amarenco P; Labreuche J
    Lancet Neurol; 2009 May; 8(5):453-63. PubMed ID: 19375663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade?
    Castilla-Guerra L; Fernandez-Moreno MDC; Leon-Jimenez D; Rico-Corral MA
    Curr Treat Options Neurol; 2019 Apr; 21(5):22. PubMed ID: 30957208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in the treatment of acute ischemic stroke.
    Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F
    Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].
    Castilla-Guerra L; Fernández-Moreno Mdel C; López-Chozas JM
    Clin Investig Arterioscler; 2016; 28(4):202-8. PubMed ID: 26150172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and stroke prevention.
    Paciaroni M; Bogousslavsky J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A; Fisman EZ; Motro M; Adler Y
    Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of statins in stroke prevention.
    Amarenco P
    Curr Opin Lipidol; 2005 Dec; 16(6):614-8. PubMed ID: 16276237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and stroke prevention.
    Shaltoni HM; Yatsu FM; Hess DC
    Curr Atheroscler Rep; 2005 Jul; 7(4):313-8. PubMed ID: 15975325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors.
    Gil-Núñez AC; Villanueva JA
    Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
    Vaughan CJ
    Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
    Moonis M; Fisher M
    Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins in Stroke.
    Aznaouridis K; Masoura C; Vlachopoulos C; Tousoulis D
    Curr Med Chem; 2019; 26(33):6174-6185. PubMed ID: 31218948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.